オレゴンにおける悪性黒色腫の臨床試験
オレゴン内の拠点で、悪性黒色腫に関する15件の研究が参加者を募集しています。
オレゴン内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- 他7件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Saint Charles Health System, Bend
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- USOR Willamette Valley Cancer Institute and Research Center, Eugene
- Kaiser Foundation Hospitals, Portland
- Oregon Health and Science University, Portland
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916Pan-tumor MRD Study
- Oregon Health & Science University (OHSU), Portland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- 他8件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013Project: Every Child for Younger Patients With Cancer
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Providence Cancer Center Oncology and Hematology Care- Eastside, Portland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04895709A Study of MGC026 in Participants With Advanced Solid Tumors
- Providence Cancer Institute, Portland
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- OHSU Knight Cancer Institute, Portland
被験者募集中第4相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07405086DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA15-0, Portland
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06953089Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Kaiser Permanente Northwest, Portland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Observational Study of Iris Tumors
- Oregon Health & Science University, Portland
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2025/09/09更新 · NCT03809585A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Oregon Health & Science University, Portland
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/02/13更新 · NCT05669430Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Kaiser Sunnyside Medical Center, Clackamas
- Kaiser Permanente Northwest - Oncology Clinic, Portland
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。